112 related articles for article (PubMed ID: 12888419)
1. Cerebrospinal fluid nitrite and malondialdehyde levels in patients with motor neuron disease.
Shukla R; Rajani M; Barthwal MK; Srivastava N; Dikshit M
Int J Neurosci; 2003 Aug; 113(8):1043-54. PubMed ID: 12888419
[TBL] [Abstract][Full Text] [Related]
2. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
[TBL] [Abstract][Full Text] [Related]
3. Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease.
Mandrioli J; Del Rio D; Zini A; Nichelli P; Merelli E; Beltrami D; Cesari C; Pellegrini N; Brighenti F; Sola P
Neurosci Lett; 2006 Jul; 401(3):203-8. PubMed ID: 16600498
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
[TBL] [Abstract][Full Text] [Related]
5. Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia.
Barber SC; Wood-Allum CA; Sargsyan SA; Walsh T; Cox LE; Monk PN; Shaw PJ
Amyotroph Lateral Scler; 2011 Jul; 12(4):257-63. PubMed ID: 21366496
[TBL] [Abstract][Full Text] [Related]
6. Nitrite/nitrate and malondialdehyde levels in nasal polyp.
Bugdayci G; Kaymakci M
Cell Mol Biol (Noisy-le-grand); 2008 Oct; 54 Suppl():OL1043-5. PubMed ID: 18954553
[TBL] [Abstract][Full Text] [Related]
7. Malondialdehyde and nitric oxide levels in the plasma of patients with advanced laryngeal cancer.
Taysi S; Uslu C; Akcay F; Sutbeyaz MY
Surg Today; 2003; 33(9):651-4. PubMed ID: 12928839
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid nitric oxide levels in subacute sclerosing panencephalitis.
Yilmaz D; Yüksel D; Senbil N; Eminzade S; Kilinç K; Anlar B; Gürer Y
Pediatr Neurol; 2009 Sep; 41(3):179-82. PubMed ID: 19664532
[TBL] [Abstract][Full Text] [Related]
9. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis.
Asahara H; Yokoi I; Tamada T; Kabuto H; Ogawab N; Mori A; Inoue H
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):77-83. PubMed ID: 8824933
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in acute ischemic stroke.
Ozkul A; Akyol A; Yenisey C; Arpaci E; Kiylioglu N; Tataroglu C
J Clin Neurosci; 2007 Nov; 14(11):1062-6. PubMed ID: 17884504
[TBL] [Abstract][Full Text] [Related]
11. Levels of nitric oxide metabolites in cerebrospinal fluid in cluster headache.
Steinberg A; Wiklund NP; Brundin L; Remahl AI
Cephalalgia; 2010 Jun; 30(6):696-702. PubMed ID: 20511209
[TBL] [Abstract][Full Text] [Related]
12. High levels of oxidative stress in patients with advanced lung cancer.
Esme H; Cemek M; Sezer M; Saglam H; Demir A; Melek H; Unlu M
Respirology; 2008 Jan; 13(1):112-6. PubMed ID: 18197920
[TBL] [Abstract][Full Text] [Related]
13. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
[TBL] [Abstract][Full Text] [Related]
14. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
Vucic S; Kiernan MC
Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
[TBL] [Abstract][Full Text] [Related]
15. Malon dialdehyde, nitrite and adrenomedullin levels in patients with premenstrual syndrome.
Balat O; Dikensoy E; Ugur MG; Atmaca R; Cekmen M; Yurekli M
Arch Gynecol Obstet; 2007 May; 275(5):361-5. PubMed ID: 17063355
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide as an activity marker in multiple sclerosis.
Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
[TBL] [Abstract][Full Text] [Related]
17. Changes in cerebrospinal fluid levels of malondialdehyde and glutathione reductase activity in multiple sclerosis.
Calabrese V; Raffaele R; Cosentino E; Rizza V
Int J Clin Pharmacol Res; 1994; 14(4):119-23. PubMed ID: 7607784
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and malondialdehyde in human hypertension.
Armas-Padilla MC; Armas-Hernández MJ; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero J; Carvajal AR; Hernández-Hernández R; Israili ZH; Valasco M
Am J Ther; 2007; 14(2):172-6. PubMed ID: 17414586
[TBL] [Abstract][Full Text] [Related]
19. Malondialdehyde and nitric oxide levels in erythrocytes from patients with systemic sclerosis.
Devrim E; Erten S; Erguder IB; Namuslu M; Turgay M; Durak I
Med Princ Pract; 2008; 17(4):349-50. PubMed ID: 18523408
[TBL] [Abstract][Full Text] [Related]
20. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
Singhania N; Puri D; Madhu SV; Sharma SB
QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
